Effects of combined epigallocatechin gallate and chlorogenic acid on metabolic parameters and pulmonary remodeling in a metabolic syndrome model: A preclinical study
Metabolic syndrome (MetS) may contribute to pulmonary fibrotic remodeling through metabolic dysregulation, oxidative stress, and inflammatory signaling. Epigallocatechin gallate (EGCG) and chlorogenic acid (CGA) have antioxidant, anti-inflammatory, and metabolic regulatory properties, but their combined effects on syst...